Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep907 | Pituitary - Clinical | ECE2016

Serum N-terminal pro brain natriuretic peptide level in patients with prolactinoma who were treated with caborgoline

Tasdelen Mustafa Rasid , Durmaz Senay Arikan , Yildirim Nesligul , Koc Eyup

Introduction and aim: Cabergoline, a long-lasting dopamine-agonist, is generally considered to be the safety drug for the treatment of prolactinoma. But, use of long time and high dose cabergoline may be a cause of cardiac valvulopathy in patient with prolactinoma. In present study, we aim to determine serum N-terminal probrain natriuretic peptide levels in patients with prolactinoma who were treated with cabergoline.Materials and methods: Thirty patient...

ea0041ep894 | Pituitary - Clinical | ECE2016

Cardiac tissue Doppler echocardiographic evaluation of patients with prolactinoma treated with cabergoline

Arikan Durmaz Senay , Rasid Tasdelen Mustafa , Yildirim Nesligul , Cifci Aydin , Gungunes Askin

Introduction and aim: There are few side effects of cabergoline which is used for medical treatment of prolactinoma. For this reason, cabergoline is considered as first-line therapy of prolactinoma. However, chronic administration of high dose cabergoline in patients with prolactinoma may be associated with valvular heart disease. The aim of this study is to evaluate left ventricular systolic and diastolic functions by conventional and tissue Doppler echocardiography in patien...